Dopamine D2High receptors stimulated by phencyclidines, lysergic acid diethylamide, salvinorin A, and modafinil.
Philip Seeman, Hong-Chang Guan, Hélène Hirbec
Synapse (New York, N.Y.) August 1, 2009 DOI: 10.1002/syn.20647 via PubMed
Summary
AI-generated from the abstractPhencyclidine and other hallucinogens and psychostimulants can activate dopamine D2 receptors in rat brain tissue, contrary to some earlier reports. Using rat striatum homogenates, phencyclidine achieved 46% of the maximum stimulation produced by dopamine, with a half-maximum concentration of 70 nM. Other compounds, including LSD, salvinorin A, R-modafinil, ketamine, and dizocilpine, also stimulated D2 receptors at concentrations related to their behavioral effects. The stimulation was blocked by a D2 antagonist and by hypertonic buffer containing sodium chloride, which may explain why previous studies failed to observe this effect.
Study at a glance
| Characteristics | Laboratory experiment Peer reviewed |
|---|---|
| Population | Rat brain striatum homogenates |
| Interventions | Phencyclidine dopamine salvinorin A lysergic acid diethylamide (LSD) R-modafinil dizocilpine ketamine S-modafinil |
| Topics | LSD |
| Keywords | Pcp phencyclidine Modafinil Brain receptors Neural receptors |
| Citations | 83 |
| Key finding | Phencyclidine and other psychostimulants and hallucinogens can stimulate dopamine D2 receptors in rat striatum at concentrations relevant to their behavioral actions. |
Abstract
Although it is commonly stated that phencyclidine is an antagonist at ionotropic glutamate receptors, there has been little measure of its potency on other receptors in brain tissue. Although we previously reported that phencyclidine stimulated cloned-dopamine D2Long and D2Short receptors, others reported that phencyclidine did not stimulate D2 receptors in homogenates of rat brain striatum. This study, therefore, examined whether phencyclidine and other hallucinogens and psychostimulants could stimulate the incorporation of [(35)S]GTP-gamma-S into D2 receptors in homogenates of rat brain striatum, using the same conditions as previously used to study the cloned D2 receptors. Using 10 microM dopamine to define 100% stimulation, phencyclidine elicited a maximum incorporation of 46% in rat striata, with a half-maximum concentration of 70 nM for phencyclidine, when compared with 80 nM for dopamine, 89 nM for salvinorin A (48 nM for D2Long), 105 nM for lysergic acid diethylamide (LSD), 120 nM for R-modafinil, 710 nM for dizocilpine, 1030 nM for ketamine, and >10,000 nM for S-modafinil. These compounds also inhibited the binding of the D2-selective ligand [(3)H]domperidone. The incorporation was inhibited by the presence of 200 microM guanylylimidodiphosphate and also by D2 blockade, using 10 microM S-sulpiride, but not by D1 blockade with 10 microM SCH23390. Hypertonic buffer containing 150 mM NaCl inhibited the stimulation by phencyclidine, which may explain negative results by others. It is concluded that phencyclidine and other psychostimulants and hallucinogens can stimulate dopamine D2 receptors at concentrations related to their behavioral actions.